Implantation of the Ventura interatrial shunt, while safe, does not improve clinical outcomes or prognosis in patients with HF and preserved LVEF.

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Consultant ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

The initial cases of Adona Medical's adjustable interatrial shunt for heart failure were conducted in the Republic of Georgia led by Dr. George Khabeishvili and supported by US experts Dr.

The Adona implant represents the next-generation of shunt technology, designed for dynamic interatrial flow that can be modified based on patient-specific hemodynamic needs," said Dr. Singh ...

As such, Johnson & Johnson could immediately utilize their global distribution channels to expand V-Wave Ventura Interatrial Shunt product worldwide. Johnson & Johnson has been building up their ...

Despite this, the company maintains a positive outlook on the acquisition, viewing V-Wave’s Ventura Interatrial Shunt device as vital for treating heart failure. Nevertheless, investors are ...

The Israeli company has now become part of Johnson & Johnson MedTech. V-Wave’s proprietary, minimally invasive Ventura Interatrial Shunt (IAS) is designed to treat patients with heart failure. The ...

Intracardiac bronchogenic cysts (IBCs) are very rare. To date, only a few cases of IBC have been reported in the literature. We report a case of a bronchogenic cyst that arose from the interatrial ...